Tvardi Therapeutics, Inc. (TVRD) vs Valion Bio, Inc. (VBIO)

A side-by-side comparison of Tvardi Therapeutics, Inc. and Valion Bio, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Tvardi Therapeutics, Inc. logo
TVRD
Tvardi Therapeutics, Inc.
$10M
$1.08HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Valion Bio, Inc. logo
VBIO
Valion Bio, Inc.
$10M
$2.38HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — TVRD vs VBIO

growth of $100 · dividends reinvested · last 1y
TVRD -76.7% (-76.7%/yr)VBIO -97.9% (-97.9%/yr)TVRD compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $1002026$23$2
TVRD VBIO

TVRD vs VBIO: by the numbers

  • •TVRD is the larger company ($10M vs $10M market cap).

Metrics side by side

Valuation

MetricTVRDVBIO
P/B ratio1.212.32

Profitability

MetricTVRDVBIO
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE-310.94%-157.76%
ROIC-323.71%-55.13%

Go deeper

Full TVRD analysisFull VBIO analysisInteractive comparison tool

Dig into the metrics

Tvardi Therapeutics ROEValion Bio ROETvardi Therapeutics operating marginValion Bio operating marginTvardi Therapeutics revenue growthValion Bio revenue growthTvardi Therapeutics free cash flowValion Bio free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.